The Psychological Impact of COVID-19 Pandemic on Persons with Multiple Sclerosis in Saudi Arabia.

IF 1.2 4区医学 Q4 CLINICAL NEUROLOGY

Neurosciences Pub Date : 2023-04-01 DOI:10.17712/nsj.2023.2.20110104

Ahmed N Alshammari, Khalid A Alshammari, Salman N Alshammari, Saad Y Aldhaifi, Abdulaziz S Alqahtani

{"title":"The Psychological Impact of COVID-19 Pandemic on Persons with Multiple Sclerosis in Saudi Arabia.","authors":"Ahmed N Alshammari, Khalid A Alshammari, Salman N Alshammari, Saad Y Aldhaifi, Abdulaziz S Alqahtani","doi":"10.17712/nsj.2023.2.20110104","DOIUrl":null,"url":null,"abstract":"Objectives: To evaluate, in a Saudi Arabian context, how the COVID-19 pandemic psychologically impacted persons with multiple sclerosis (PwMS).Methods: A cross-sectional study was undertaken during the period from October 2021 to March 2022. 738 participants resident in the Kingdom of Saudi Arabia (KSA) completed a self-administered online questionnaire. The research focused on persons diagnosed with MS.Results: Participant ages spanned from 18 to over 55. The mean was 36.1±12.9 years old. Four hundred eighty-nine (66.3%) of the 738 participants were female. Two hundred sixty-four (35.8%) were single. Four hundred twelve (55.8%) were married. Six hundred eighty-five (92.8%) had received a COVID-19 vaccine. Regarding MS duration, 117 (15.9%) had been diagnosed for less than 2 years, 171 (23.2%) for 2-5 years, while 251 (34%) had the condition for 10 or more years. Regarding psychological health, 11.2% of participants complained of minimal/no depression, 33.3% of mild depression, 28.3% of moderate depression, and 27.1% of moderately severe to severe depression symptoms. Concerning anxiety, 17.2% of participants reported minimal anxiety, 36.9% mild, 23.3% moderate, while 22.6% suffered from severe anxiety symptoms.Conclusion: A high prevalence of depression and anxiety was found, along with high prevalence of co-occurrence of these disorders among PwMS.","PeriodicalId":19284,"journal":{"name":"Neurosciences","volume":null,"pages":null},"PeriodicalIF":1.2000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1b/9d/Neurosciences-28-2-108.PMC10155471.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurosciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.17712/nsj.2023.2.20110104","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives: To evaluate, in a Saudi Arabian context, how the COVID-19 pandemic psychologically impacted persons with multiple sclerosis (PwMS).

Methods: A cross-sectional study was undertaken during the period from October 2021 to March 2022. 738 participants resident in the Kingdom of Saudi Arabia (KSA) completed a self-administered online questionnaire. The research focused on persons diagnosed with MS.

Results: Participant ages spanned from 18 to over 55. The mean was 36.1±12.9 years old. Four hundred eighty-nine (66.3%) of the 738 participants were female. Two hundred sixty-four (35.8%) were single. Four hundred twelve (55.8%) were married. Six hundred eighty-five (92.8%) had received a COVID-19 vaccine. Regarding MS duration, 117 (15.9%) had been diagnosed for less than 2 years, 171 (23.2%) for 2-5 years, while 251 (34%) had the condition for 10 or more years. Regarding psychological health, 11.2% of participants complained of minimal/no depression, 33.3% of mild depression, 28.3% of moderate depression, and 27.1% of moderately severe to severe depression symptoms. Concerning anxiety, 17.2% of participants reported minimal anxiety, 36.9% mild, 23.3% moderate, while 22.6% suffered from severe anxiety symptoms.

Conclusion: A high prevalence of depression and anxiety was found, along with high prevalence of co-occurrence of these disorders among PwMS.

Abstract Image

查看原文本刊更多论文

COVID-19大流行对沙特阿拉伯多发性硬化症患者的心理影响

目的:在沙特阿拉伯的背景下，评估COVID-19大流行对多发性硬化症(PwMS)患者的心理影响。方法:在2021年10月至2022年3月期间进行横断面研究。居住在沙特阿拉伯王国(KSA)的738名参与者完成了一份自我管理的在线问卷。研究的重点是被诊断患有多发性硬化症的人。结果:参与者的年龄从18岁到55岁以上。平均年龄为36.1±12.9岁。738名参与者中有489名(66.3%)是女性。264人(35.8%)是单身。412人(55.8%)已婚。685人(92.8%)接种了新冠肺炎疫苗。在MS病程方面，117例(15.9%)诊断少于2年，171例(23.2%)诊断为2-5年，251例(34%)诊断为10年或10年以上。在心理健康方面，11.2%的参与者抱怨有轻微或无抑郁，33.3%的人有轻度抑郁，28.3%的人有中度抑郁，27.1%的人有中度至重度抑郁症状。在焦虑方面，17.2%的参与者报告轻微焦虑，36.9%的参与者报告轻度焦虑，23.3%的参与者报告中度焦虑，22.6%的参与者报告严重焦虑症状。结论:抑郁症和焦虑症的患病率较高，同时这些疾病在PwMS患者中的发生率也较高。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Neurosciences 医学-临床神经学

CiteScore

1.40

自引率

0.00%

发文量

审稿时长

4.5 months

期刊介绍： Neurosciences is an open access, peer-reviewed, quarterly publication. Authors are invited to submit for publication articles reporting original work related to the nervous system, e.g., neurology, neurophysiology, neuroradiology, neurosurgery, neurorehabilitation, neurooncology, neuropsychiatry, and neurogenetics, etc. Basic research withclear clinical implications will also be considered. Review articles of current interest and high standard are welcomed for consideration. Prospective workshould not be backdated. There are also sections for Case Reports, Brief Communication, Correspondence, and medical news items. To promote continuous education, training, and learning, we include Clinical Images and MCQ’s. Highlights of international and regional meetings of interest, and specialized supplements will also be considered. All submissions must conform to the Uniform Requirements.